Top Canavan disease Doctors in India

At Max Hospital India, expert care is available for a wide range of conditions, including Canavan disease. Our top specialists provide advanced treatments using cutting-edge technology, ensuring the best possible care for Canavan disease. Whether through video consultations or in-person visits, patients receive personalised treatment tailored to their needs. Explore our doctors' qualifications, experience, and areas of expertise. Our seamless online booking system makes scheduling appointments and checking OPD timings quick and hassle-free. Visit Max Hospital India for trusted, high-quality healthcare.

Frequently Asked Questions

Canavan disease is a rare genetic disorder that affects the development of the brain. It is caused by a mutation in the ASPA gene, which leads to the accumulation of a substance called N-acetyl-L-aspartic acid (NAA) in the brain.

Canavan disease is inherited in an autosomal recessive manner, which means that both parents must carry a mutated ASPA gene and pass it on to their child for the disease to develop.

The symptoms of Canavan disease usually appear in early infancy and may include poor muscle tone, developmental delays, feeding difficulties, seizures, and an abnormally large head (macrocephaly).

Canavan disease can be diagnosed through genetic testing, which looks for mutations in the ASPA gene. MRI of the brain can show characteristic abnormalities associated with the disease.

Currently, there is no cure for Canavan disease. Treatment mainly focuses on managing the symptoms.

Treatment options for Canavan disease are limited. Supportive care, such as physical therapy and occupational therapy, can help manage symptoms and improve mobility. Medications may be used to control seizures and other associated complications.

The life expectancy for individuals with Canavan disease varies. In severe cases, life expectancy may be reduced, while individuals with milder forms of the disease may have a normal lifespan.

Yes, prenatal testing is available for Canavan disease. It involves analysing a sample of cells from the fetus to determine if they carry the ASPA gene mutation.

Carriers of Canavan disease typically do not have symptoms themselves. The condition only manifests if both copies of the ASPA gene are mutated.

The primary risk factor for Canavan disease is having Ashkenazi Jewish ancestry. The mutation in the ASPA gene is more common in this population.

In some regions, Canavan disease is included in newborn screening programs. The screening involves testing a small blood sample from the baby to identify genetic conditions, including Canavan disease.

The ability of individuals with Canavan disease to attend school depends on the severity of their symptoms and the level of support available. In some cases, specialised educational programs may be necessary.

Canavan disease is typically diagnosed in infancy or early childhood due to the appearance of symptoms.

Canavan disease primarily affects the brain and its development. It does not typically involve other organs in the body.

The ASPA gene provides instructions for producing an enzyme called aspartoacylase. Mutations in this gene result in reduced or absent aspartoacylase activity, leading to the accumulation of N-acetyl-L-aspartic acid (NAA) in the brain.

Canavan disease is an autosomal recessive disorder, which means that both parents must carry a mutated ASPA gene and pass it on to their child for the disease to develop.

FAQs reviewed by Dr. Manoj Khanal, Associate Director, Neurosciences, Neurology, Interventional Neurology.

Top Canavan disease Doctors in India

Filters

Doctors Available

Frequently Asked Questions

Common Conditions Treated in India

Canavan disease Doctors in Other Location

Top Specialities

Health Calculators